Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

July 12, 2021

Study Completion Date

April 28, 2022

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

Lebrikizumab

Subcutaneous injection

OTHER

Placebo

Subcutaneous Injection

Trial Locations (89)

235

Taipei Medical University- Shuang Ho Hospital, New Taipei City

402

Chung Shan Medical University Hospital, Taichung

807

Kaohsiung Medical University Chung-Ho Institutional Review B, Kaohsiung City

833

Kaohsiung Chang Gung Memorial Hospital, Niaosong Dist

1408

Diagnostic and Consultation Center 14, Sofia

1432

Alexandrovska University Hospital, Sofia

1606

Euro Derma clinic, Sofia

Military Medical Academy, Sofia

1618

Medical centre Alitera-Med EOOD, Sofia

4000

DCC Sveti Georgi, Plovdiv

10002

National Taiwan University Hospital, Taipei

10117

Charité Universitätsmedizin Berlin Campus Buch, Berlin

10789

ISA GmbH, Berlin

11415

Forest Hills Dermatology Group, Kew Gardens

13055

Praxis für Ganzheitliche Dermatologie im Ärztehaus, Berlin

15241

Peak Research LLC, Upper Saint Clair

18201

DermDOX, Hazleton

19341

Dermatology and Skin Surgery Center, Exton

20130

Derma Norte del Bajío, S.C., Aguascalientes

20246

Universitätsklinikum Hamburg, Hamburg

20537

TFS Trial Form Support GmbH, Hamburg

21614

Elbe Klinikum Buxtehude, Buxtehude

23502

Virginia Clinical Research, Inc., Norfolk

23538

Universitätsklinikum Schleswig-Holstein, Lübeck

28277

OnSite Clinical Solutions, Charlotte

28405

Wilmington Dermatology Center, Wilmington

29407

Dermatology & Laser Center of Charleston, Charleston

29601

Palmetto Clinical Trial Services, Greenville

30060

Marietta Dermatology Clinical Research, Marietta

30328

Advanced Medical Research, Sandy Springs

31707

Georgia Pollens Clinical Research Centers, Inc, Albany

32256

Solutions Through Advanced Research, Inc., Jacksonville

33012

Direct Helpers Medical Center, Hialeah

33016

The Community Research of South Florida, Hialeah

33305

Chang Gung Memorial Hospital - Linkou, Taoyuan

39028

Rivne Regional Dermatology and Venereology Dispensary, Rivne

40447

China Medical University Hospital, Taichung

44793

Hautzentrum im Jahrhunderthaus, Bochum

48149

Universitätsklinikum Münster, Münster

48346

Clarkston Skin Research, Clarkston

48455

Fachklinik Bad Bentheim, Bad Bentheim

48706

Great Lakes Research Group, Inc., Bay City

49074

Klinische Forschung Osnabrück, Osnabrück

55432

Associated Skin Care Specialists, Fridley

60008

Arlington Dermatology, Rolling Meadows

60077

NorthShore University HealthSystem, Skokie

60590

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt am Main

61038

Municipal Healthcare Institution Kharkiv City Dermatoverenologic Dispensary N2, Kharkiv

63117

Central Dermatology PC, St Louis

64283

Rosenpark Research Geschäftsbereich der Rosenparkklinik GmbH, Darmstadt

66215

Kansas City Dermatology, PA, Overland Park

69000

Community Institution Zaporizhzhya Regional Dermatovenereology Clinical Hospital of Zaporizhzhya Regional Council, Zaporizhzhya

70499

Hautarztpraxis am Löwenmarkt, Stuttgart

70808

Meridian Clinical Research, Baton Rouge

72758

Northwest Arkansas Clinical Trials Center, Rogers

76011

Arlington Research Center, Inc, Arlington

76244

Innovate Research, LLC, Fort Worth

78660

Austin Institute for Clinical Research, Pflugerville

84107

University of Utah MidValley Dematology, Murray

85255

Investigate MD, Scottsdale

86150

Praxis Dr. Michael Dietlen, Augsburg

86179

licca Fachklinik, Augsburg

88002

"Treatment-diagnostic center PE Asclepius", Uzhhorod

88045

Derma-Study-Center Friedrichshafen GmbH, Friedrichshafen

89129

Studienzentrum Dr.Beate Schwarz, Langenau

90045

Dermatology Research Associates, Los Angeles

90057

LA Universal Research Center, INC, Los Angeles

92123

University Clinical Trials, Inc., San Diego

93309

Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield

93405

San Luis Dermatology & Laser Clinic, San Luis Obispo

93720

Woodward Centre, Fresno

94538

Center For Dermatology Clinical Research, Inc., Fremont

98101

Dermatology Associates, Seattle

119074

National University Hospital, Singapore

169078

Singapore General Hospital, Singapore

229899

Kk Women'S and Childrens Hospital, Singapore

308205

National Skin Centre NSC, Singapore

33916-9452

Clinical Physiology Associates, Clinical Study Center, Fort Myers

01915

ActivMed Practices and Research, Beverly

02111

Tufts Medical Center, Boston

V3R 6A7

Dr. Chih-ho Hong Medical Inc., Surrey

L4M 7G1

Simcoderm Medical & Surgical Dermatology Centre, Barrie

L3P1X2

Lynderm Research Inc., Markham

M2M4J5

North York Research Inc., North York

K1G 6C6

Ottawa Allergy Research Corp, Ottawa

N2J 1C4

K. Papp Clinical Research, Waterloo

04103

SIBAmed Studienzentrum GmbH & Co. KG, Leipzig

Universität Leipzig - Universitätsklinikum, Leipzig

CP 58249

Clinica De Enfermedades Cronicas y Procedimientos Especiales, Morelia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dermira, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT04178967 - Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter